Author:
Burshell Alan L.,Möricke Rüdiger,Correa-Rotter Ricardo,Chen Peiqi,Warner Margaret R.,Dalsky Gail P.,Taylor Kathleen A.,Krege John H.
Subject
Histology,Physiology,Endocrinology, Diabetes and Metabolism
Reference31 articles.
1. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring;Garnero;Mol. Diagn. Ther.,2008
2. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis;Jacobs;J. Rheumatol.,2007
3. Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women;Bjarnason;Bone,2000
4. Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group;Ravn;Bone,1999
5. Early Changes in Biochemical Markers of Bone Turnover Are Associated with Long-Term Changes in Bone Mineral Density in Elderly Women on Alendronate, Hormone Replacement Therapy, or Combination Therapy: A Three-Year, Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献